Skip to main content
HR 383 105th Congress House Health Armed Forces and National Security Authorization Cancer research Chemotherapy Department of Health and Human Services Drugs Economics and Public Finance Education Federal aid to medical research Government Operations and Politics Government publicity Health counseling Health education Higher education Medical education Medical fees Medical screening Medical tests Medicare

Prostate Cancer Diagnosis and Treatment Act of 1997

Introduced: January 9, 1997 See on congress.gov
 Everywhere this bill has been 9 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 5, 1997
See H.R.2015.
Feb 24, 1997
Referred to the Subcommittee on Health.
Jan 23, 1997
Referred to the Subcommittee on Health and Environment.
Jan 17, 1997
Referred to the Subcommittee on Health.
Jan 9, 1997
Referred to House Veterans' Affairs
Jan 9, 1997
Referred to House Ways and Means
Jan 9, 1997
Referred to the Committee on Commerce, and in addition to the Committees on Ways and Means, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 9, 1997
Referred to House Commerce
Jan 9, 1997
Introduced in House
 Plain-English summary Congressional Research Service

Prostate Cancer Diagnosis and Treatment Act of 1997 - Amends title XVIII (Medicare) of the Social Security Act to provide for coverage of services for the early detection of prostate cancer and certain drug treatments for such cancer. Requires the Secretary of Health and Human Services to establish fee schedules for such services.

Amends Federal law to cover such detection and treatment services for veterans as a preventive health service.

Amends the Public Health Service Act to authorize appropriations for certain public health programs related to prostate cancer research and education.

Directs the Administrator of the Agency for Health Care Policy and Research to: (1) conduct and support research on prostate cancer health services and procedures; and (2) provide for the development, periodic review, and updating of clinically relevant guidelines, standards of quality, performance measures, and medical review criteria.

What's happening now August 5, 1997

See H.R.2015.

 Committees of jurisdiction 6